New strategy of therapy for functional dyspepsia using famotidine, mosapride and amitriptyline
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Summary: Background : In functional gastrointestinal (GI) disorders including functional dyspepsia (FD) and irritable bowel syndrome (IBS), there might be no small extent of contributions of psychosomatic factors. As a therapy for IBS patients, the effectiveness of antidepressants has been reported. Aim : In this study, we evaluated the efficacy of H 2‐receptor antagonist (famotidine) and 5‐HT 4 receptor agonist (mosapride citrate). In addition, the effect of antidepressants was assessed as the second‐step therapy. Methods : Patients complaining upper GI symptoms were diagnosed as FD excluding organic diseases. Randomized patients received 20 mg/day of famotidine or 15 mg/day of mosapride citrate for 4 weeks and the efficacy was compared between the two groups based on a 10‐point visual analogue scale. When symptoms were not relieved (score improvement 0–2 points), patients received amitriptyline (30 mg/day) or no medication for 4 weeks randomly. Patients who had depression in psychological test (SDS) were omitted. Results : As the first‐step therapy, both famotidine and mosapride showed beneficial effects regardless of FD subtypes, age and gender. The efficacy of these two drugs in relieving FD symptoms was not significantly different. In patients who failed in the first‐step therapy, amitriptyline showed beneficial effects. Conclusions : These findings might be clinically important in view of the efficient relief of symptoms in FD patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functional Gastroduodenal Disorders
Tack, J., Talley, N. J., Camilleri, M., Holtmann, G., Hu, P., Malagelada, J.-R., & Stanghellini, V. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.059 · Cited by 2,418
Drossman, D. A., Li, Z., Andruzzi, E., Temple, R. D., Talley, N. J., Grant Thompson, W., Whitehead, W. E., Janssens, J., Funch-Jensen, P., Corazziari, E., et al. (1993) · Digestive Diseases and Sciences · doi:10.1007/bf01303162 · Cited by 2,198
Sheehan, D. V., Harnett-Sheehan, K., & Raj, B. A. (1996) · International Clinical Psychopharmacology · doi:10.1097/00004850-199606003-00015 · Cited by 1,440
Assessing impairment in patients with panic disorder: the Sheehan Disability Scale
Leon, A. C., Shear, M. K., Portera, L., & Klerman, G. L. (1992) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/bf00788510 · Cited by 319
Fundamentals of neurogastroenterology
Wood, J. D., Alpers, D. H., & Andrews, P. L. R. (1999) · Gut · doi:10.1136/gut.45.2008.ii6 · Cited by 311
Mertz, H., Fass, R., Kodner, A., Yan-Go, F., Fullerton, S., & Mayer, E. A. (1998) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1998.00160.x · Cited by 220
Cited by
Talley, N. J., Locke, G. R., Saito, Y. A., Almazar, A. E., Bouras, E. P., Howden, C. W., Lacy, B. E., DiBaise, J. K., Prather, C. M., Abraham, B. P., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.020 · Cited by 333
Saps, M., Youssef, N., Miranda, A., Nurko, S., Hyman, P., Cocjin, J., & Di Lorenzo, C. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.06.060 · Cited by 254
Review article: current treatment options and management of functional dyspepsia
Lacy, B. E., Talley, N. J., Locke, G. R., Bouras, E. P., DiBaise, J. K., El‐Serag, H. B., Abraham, B. P., Howden, C. W., Moayyedi, P., & Prather, C. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2012.05128.x · Cited by 192
Pharmacological interventions for non-ulcer dyspepsia
Moayyedi, P., Shelly, S., Deeks, J. J., Delaney, B., Innes, M., & Forman, D. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001960.pub3 · Cited by 99
RetractedGrover, M., & Camilleri, M. (2013) · Journal of Gastroenterology · doi:10.1007/s00535-012-0726-5 · Cited by 65
“Significant benefits were observed in the amitriptyline groups [16].”
Background
Metadata
- Authors
- Otaka, M., Jin, M., Odashima, M., Matsuhashi, T., Wada, I., Horikawa, Y., Komatsu, K., Ohba, R., Oyake, J., Hatakeyama, N., & Watanabe, S.
- Venue
- Alimentary Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2005-06
- Volume
- 21
- Issue
- s2
- Pages
- 42-46
- ISSN
- 0269-2813 (ISSN-L)
- 1365-2036
- OpenAlex
- W2086872452
- Cited by
- 71
- References
- 6
- FWCI
- 5.17
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: New strategy of therapy for functional dyspepsia using famotidine, mosapride and amitriptyline. https://app.cochat.ai/papers/10.1111/j.1365-2036.2005.02473.x
- The paper
- Otaka, M., Jin, M., Odashima, M., Matsuhashi, T., Wada, I., Horikawa, Y., Komatsu, K., Ohba, R., Oyake, J., Hatakeyama, N., & Watanabe, S. (2005). New strategy of therapy for functional dyspepsia using famotidine, mosapride and amitriptyline. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/j.1365-2036.2005.02473.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.